Log in to save to my catalogue

Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymp...

Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymp...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037007

Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas

About this item

Full title

Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas

Publisher

Germany: Springer Nature B.V

Journal title

Cancer Immunology, Immunotherapy, 2000-10, Vol.49 (8), p.449-458

Language

English

Formats

Publication information

Publisher

Germany: Springer Nature B.V

More information

Scope and Contents

Contents

Peripheral blood mononuclear cells (PBMC) from cancer patients were cultured in vitro with irradiated autologous tumor cells isolated from malignant effusions (mixed lymphocyte tumor cultures, MLTC) and low-dose (50 IU/ml) recombinant interleukin-2 (IL-2). The combination of IL-2 and prothymosin alpha (ProTalpha) resulted in a greater PBMC-induced...

Alternative Titles

Full title

Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037007

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037007

Other Identifiers

ISSN

0340-7004

E-ISSN

1432-0851

DOI

10.1007/s002620000132

How to access this item